 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Contact:
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
(414) 977-4254
bethfj@merge.com
|
|
Richard Linden, President and CEO
Merge Healthcare
(414) 977-4000
rlinden@merge.com
|
|
MERGE EMED ANNOUNCES USER GROUP MEETING FOR RIS, PACS
AND CLINICAL APPLICATION CUSTOMERS
Milwaukee, WI, January 24, 2006 – Merge eMed, a Merge Healthcare company and a leading healthcare software and services company, today announced that it will hold its 2006 User Group Meeting for its RIS, PACS, and Clinical Application customers, May 7 - 9, 2006, in Boston. The meeting, to be held at the Park Plaza Hotel, will include RIS, PACS and clinical application software presentations by Merge eMed staff, and best practice sessions presented by Merge eMed customers. In addition, participants will provide feedback on product roadmaps and develop relationships among users for post-meeting networking with other users about best practices, optimizing workflow and other ideas to accelerate productivity. Several members of Merge eMed's Customer Advisory Panel are assisting in the planning of the event.
"Our solutions are created to resolve our customers' business issues," said David Noshay, Merge eMed President. "Our users have a continual need to learn new ways to accelerate productivity, grow their revenues and expand their reach and services to referring physicians. The user group meeting provides an opportunity for radiologists, imaging center managers, PACS and RIS administrators, radiology managers, IT staff, billing managers and others to learn new ways to improve workflow, speed productivity and improve profitability within their organizations. Our last User Group Meeting was rated very highly by the participants, and we look forward to meeting the many new customers that have joined us this past year," said Noshay. For more information please visit www.merge-emed.com.
###
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. With over twenty years of leadership in the medical imaging and healthcare information technology markets, Merge Healthcare provides innovative solutions for both OEM and the end-user healthcare markets. We custom engineer clinical and imaging applications and development tools that are on the forefront of medicine and its use of medical imaging for OEM and international customers. We develop innovative medical imaging software solutions that support end-to-end business and clinical workflow for radiology department and specialty practices, imaging centers and hospitals. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
Merge eMed, a Merge Healthcare company,is focused on accelerating productivity for radiology department and specialty practices, imaging centers and hospitals. By combining sophisticated RIS, PACS, advanced visualization and clinical imaging applications, Merge eMed delivers integrated end-to-end software solutions and professional services that are transforming the way our customers interact with referring physicians, manage their workflow, position their businesses in their markets and deliver imaging and information services to their customers. We ensure our customers' success in today's competitive healthcare environment by streamlining business and clinical workflow with digital image and information solutions and services.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
